ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
This intro outlines practical zero based budgeting essentials, helping you assign every dollar to a purpose and track progress toward your goals.
20,375 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...
Tech giants drive a broad market surge as AI earnings power gains push the Nasdaq toward a nasdaq defy gravity record...
Gusto, the San Francisco-based HR software maker, posts more than $1 billion in trailing revenue for the last 12 mont...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
As Innodata prepares to unveil its Q1 2026 results, investors want clarity on growth drivers, margins, and the path t...
As 2026 unfolds, Main Street stocks like MAIN reveal how middle-market finance navigates rising rates and credit shif...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
A Qatar-linked LNG carrier crossed Hormuz, the first export through the strait since the war intensified. The move co...
As the economy ebbs and flows, some stocks stand out for their hard-to-replace value. This piece explores why costco ...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
Greenboard closes a $15.5 million Series A to scale its AI-driven compliance platform, expanding to more banks and fi...